165 related articles for article (PubMed ID: 22226370)
1. IL-21 and Sjögren's syndrome.
Scofield RH
Arthritis Res Ther; 2011; 13(6):137. PubMed ID: 22226370
[TBL] [Abstract][Full Text] [Related]
2. Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.
Kang KY; Kim HO; Kwok SK; Ju JH; Park KS; Sun DI; Jhun JY; Oh HJ; Park SH; Kim HY
Arthritis Res Ther; 2011; 13(5):R179. PubMed ID: 22030011
[TBL] [Abstract][Full Text] [Related]
3. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
[TBL] [Abstract][Full Text] [Related]
4. Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Blokland SLM; Hillen MR; Wichers CGK; Zimmermann M; Kruize AA; Radstake TRDJ; Broen JCA; van Roon JAG
RMD Open; 2019; 5(1):e000701. PubMed ID: 30713717
[No Abstract] [Full Text] [Related]
5. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE
J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
[TBL] [Abstract][Full Text] [Related]
6. [A diagnostic and etiologic studies of Sjögren's syndrome--I. Sialographical and histopathological findings of the major and minor salivary glands].
Tanaka O
Nihon Jibiinkoka Gakkai Kaiho; 1989 Mar; 92(3):362-73. PubMed ID: 2754525
[TBL] [Abstract][Full Text] [Related]
7. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome.
Awada A; Nicaise C; Ena S; Schandéné L; Rasschaert J; Popescu I; Gangji V; Soyfoo MS
Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic analysis of 25 Sjögren's syndrome cases.
Ge MZ; Qi WN; Zhang Y
Chin Med J (Engl); 1981 Jun; 94(6):365-8. PubMed ID: 6788477
[No Abstract] [Full Text] [Related]
9. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
[TBL] [Abstract][Full Text] [Related]
10. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.
Cortés J; Hidalgo J; Aguilera S; Castro I; Brito M; Urra H; Pérez P; Barrera MJ; Carvajal P; Urzúa U; González S; Molina C; Bahamondes V; Hermoso M; González MJ
J Autoimmun; 2019 Feb; 97():88-99. PubMed ID: 30391023
[TBL] [Abstract][Full Text] [Related]
11. [Sicca syndrome resulting from primary amyloidosis].
Bollerslev J; van der Mark S; Baunsgaard P
Ugeskr Laeger; 1985 Dec; 147(49):4013. PubMed ID: 4090025
[No Abstract] [Full Text] [Related]
12. [Salivary gland examinations in patients with rheumatoid arthritis].
Shimoyama K; Ogawa N
Nihon Rinsho; 2005 Jan; 63 Suppl 1():386-9. PubMed ID: 15799384
[No Abstract] [Full Text] [Related]
13. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
15. [Sjögren's syndrome].
Tylczyński W
Otolaryngol Pol; 1977; 31(3):369-80. PubMed ID: 331194
[No Abstract] [Full Text] [Related]
16. Dual function of miR-1248 links interferon induction and calcium signaling defects in Sjögren's syndrome.
Jang SI; Tandon M; Teos L; Zheng C; Warner BM; Alevizos I
EBioMedicine; 2019 Oct; 48():526-538. PubMed ID: 31597594
[TBL] [Abstract][Full Text] [Related]
17. The influence of sex steroids on Sjögren's syndrome.
Porola P; Laine M; Virkki L; Poduval P; Konttinen YT
Ann N Y Acad Sci; 2007 Jun; 1108():426-32. PubMed ID: 17894007
[TBL] [Abstract][Full Text] [Related]
18. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
19. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of Sjögren's syndrome.
García-Carrasco M; Fuentes-Alexandro S; Escárcega RO; Salgado G; Riebeling C; Cervera R
Arch Med Res; 2006 Nov; 37(8):921-32. PubMed ID: 17045106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
